A Vaccine Aimed at Preventing Pancreatic Cancer Cleared Its First Human Safety Test in 20 High-Risk Adults

Johns Hopkins researchers report immune responses in 18 of 20 participants at inherited risk of pancreatic cancer. The trial did not test prevention.

Have A Referral?